Overall, these data suggest that cell line genetics determine the establishment of different TIMEs, while the resulting intratumoral IFN-γ concentration maintains and intensifies these differences in synchronous melanoma tumors, as exemplified by the tumor-specific regulation of H2-Kb and PD-L1 expressions. The gene discussed is IFNG; the disease is melanoma.